Reid G. Adler

VTGN

CHIEF LEGAL OFFICER · VISTAGEN THERAPEUTICS, INC. · CIK 0001924908

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

$85.7K

COMPANIES

ACTIVE SINCE

May 2022

HOLDINGS NOW

60,868

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

1 backtested trades · 8 horizons

Forward-return performance of every backtestable P/S trade by Reid G. Adler, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	1	+100.00%	+8.34%	-3.04%	+11.38%	+11.38%	—
14d	1	+0.00%	-4.71%	-7.38%	+2.66%	+2.66%	—
30d	1	+0.00%	-1.09%	-9.26%	+8.17%	+8.17%	—
60d	1	+0.00%	-41.64%	-13.67%	-27.97%	-27.97%	—
90d	1	+0.00%	-17.61%	-6.22%	-11.39%	-11.39%	—
180d	1	+100.00%	+18.54%	-2.39%	+20.93%	+20.93%	—
1y	1	+0.00%	-4.37%	+3.93%	-8.30%	-8.30%	—
2y	1	+0.00%	-43.38%	+33.89%	-77.27%	-77.27%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

VTGN · 60,868 shares · as of Jun 30, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2022

2023

2024

2025

2026

FLOW · 11 buys / 0 sellsCOVERAGE · 17 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	36,818	$0.19	$7.1K	60,868	Jun 30, 2026	Jul 2, 2026 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	56,247	—	—	56,247	Apr 7, 2026	Apr 9, 2026 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	18,753	—	—	18,753	Apr 7, 2026	Apr 9, 2026 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	7,541	$1.70	$12.8K	24,050	Jun 30, 2025	Jul 1, 2025 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	100,000	—	—	100,000	Jun 23, 2025	Jun 25, 2025 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	4,854	$2.96	$14.4K	16,509	Jun 28, 2024	Jul 2, 2024 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	170,000	—	—	170,000	Jun 24, 2024	Jun 26, 2024 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	167	$1.72	$287	11,655	Dec 29, 2023	Jan 3, 2024 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	167	$1.59	$265	11,488	Jun 30, 2023	Jul 5, 2023 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASE CHIEF LEGAL OFFICER	300,000	$0.17	$50.9K	334,629	Aug 17, 2022	Aug 19, 2022 ↗	View →
VTGN VISTAGEN THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	200,000	—	—	200,000	May 2, 2022	May 3, 2022 ↗	View →

Other insiders · VTGN

Loading peer insiders…

About this filer

CIK 0001924908

ROLE

Chief Legal Officer

PRIMARY

VTGN

COMPANIES

ACTIVE SINCE

May 2022

MARKETPEEL · /INSIDER/0001924908DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Reid G. Adler

The morning brief, before the bell.